
Myasthenia Gravis
Myasthenia Gravis
Myasthenia Gravis is a chronic autoimmune disorder characterized by progressive muscle weakness, especially in the muscles of the face, neck, and limbs. Effective treatment typically involves immunosuppressive therapy to manage symptoms and improve quality of life.
Read our guide to: Myasthenia Gravis
Myasthenia Gravis
How Myasthenia Gravis Medications Work
Myasthenia gravis is an autoimmune disease characterized by muscle weakness and fatigue. The condition occurs when the immune system produces antibodies that block or destroy the receptors for acetylcholine, a neurotransmitter responsible for transmitting signals from nerve cells to muscles.
Treatment with Immunomodulatory Therapies
The gold standard treatment for myasthenia gravis is immunosuppressive therapy. This involves using medications that suppress the immune system's abnormal response and reduce the production of antibodies against acetylcholine receptors. Common immunosuppressants used to treat myasthenia gravis include:
- Corticosteroids (e.g., prednisone): These are often the first line of treatment for mild to moderate disease.
- Azathioprine: This is an immunosuppressive medication that can be used alone or in combination with corticosteroids.
- Mycephenolate mofetil: Another immunosuppressant that may be used to treat myasthenia gravis, especially in patients who are unable to tolerate other treatments.
Alternative Therapies
For patients who do not respond to or cannot tolerate immunosuppressive therapy, alternative treatments may be considered. These include:
- Plasmapheresis: A procedure that involves removing antibodies from the blood and replacing them with healthy ones.
- Intravenous immunoglobulin (IVIG): This involves administering antibodies to help neutralize the effects of autoantibodies in the body.